Sharon D. Bryant
Chief Executive Officer
Bioinformatics
Inte:Ligand
Austria
Biography
Sharon Bryant joined Inte:Ligand in 2009 as CEO. She was previously a Research Scientist at the National Institutes of Health (NIH) for 17 years. Her research involved molecular modeling of novel opioid peptide derivatives, opioid G-protein coupled receptors, and development of pharmacophores to identify structural templates for novel lead compounds for investigative research and therapeutic drugs. She has authored and co-authored more than 60 peer reviewed research articles, several reference volumes and software reviews and almost 50 conference proceedings and is an active member of numerous international professional societies and committees.
Research Interest
molecular modeling
